Results 61 to 70 of about 8,923 (197)

A Rare Case of HIV-Induced Inflammatory Demyelinating Polyneuropathy.

open access: yes, 2019
Background:Acute inflammatory demyelinating polyneuropathy (AIDP) is an uncommon form of neuropathy in HIV-infected patients that can cause pain, sensory disturbance, and motor weakness.
Zahid, S.   +6 more
core   +1 more source

Postmortem Findings in Patient with Guillain-Barré Syndrome and Zika Virus Infection

open access: yesEmerging Infectious Diseases, 2018
Postmortem examination results of a patient with Guillain-Barré syndrome and confirmed Zika virus infection revealed demyelination of the sciatic and cranial IV nerves, providing evidence of the acute demyelinating inflammatory polyneuropathy Guillain ...
Emilio Dirlikov   +11 more
doaj   +1 more source

Clinical Practice Guideline for Evaluation and Management of Peripheral Nervous System Manifestations in Sjögren's Disease

open access: yesArthritis Care &Research, Volume 78, Issue 7, Page 860-874, July 2026.
Objective Sjögren's disease is an autoimmune disorder that can impact multiple organ systems, including the peripheral nervous system (PNS). PNS manifestations, which can exist concurrently, include mononeuropathies, polyneuropathies, and autonomic nervous system neuropathies.
Anahita Deboo   +88 more
wiley   +1 more source

Guillain‐Barré Syndrome Following Herpes Zoster Ophthalmicus: A Rare Case of Acute Motor Axonal Neuropathy

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Herpes zoster ophthalmicus (HZO) refers to reactivation of varicella–zoster virus involving the ophthalmic division of the trigeminal nerve. Guillain‐Barré syndrome (GBS) has been infrequently reported following herpes zoster infection, and its occurrence after HZO is particularly uncommon.
Asad Ullah Khan   +8 more
wiley   +1 more source

Early Electrodiagnostic Features of Upper Extremity Sensory Nerves Can Differentiate Axonal Guillain-Barré Syndrome from Acute Inflammatory Demyelinating Polyneuropathy [PDF]

open access: yes, 2017
BACKGROUND AND PURPOSE: Serial nerve conduction studies (NCSs) are recommended for differentiating axonal and demyelinating Guillain-Barr? syndrome (GBS), but this approach is not suitable for early diagnoses. This study was designed to identify possible
신하영
core   +1 more source

Childhood chronic inflammatory demyelinating polyneuropathy

open access: yes, 2017
Przewlekła zapalna polineuropatia demielinizacyjna (Chronic inflammatory demyelinating polyneuropathy, CIDP) jest rzadką chorobą o podłożu autoimmunologicznym charakteryzującą się postępującym niedowładem i/lub zaburzeniami czucia oraz hipo- lub ...
Łukawska, Małgorzata   +2 more
core   +1 more source

Pediatric Therapeutic Plasma Exchange: Characterization of Practice, Epidemiology, and Safety Profile at a Children's Hospital in the United States

open access: yesJournal of Clinical Apheresis, Volume 41, Issue 3, June 2026.
ABSTRACT There is a need to better understand the indications and safety profiles for therapeutic plasma exchange (TPE) in children. We aimed to assess pediatric TPE practice at a large academic center by retrospective chart review from 2011 to 2022. Patient demographics and clinical information including American Society for Apheresis (ASFA) category ...
Benjamin C. Lee   +4 more
wiley   +1 more source

Acquired inflammatory demyelinating polyneuropathies: Clinical and electrodiagnostic features [PDF]

open access: yes, 1989
The acquired demyelinating polyneuropathies include acute (AIDP, Guillain-BarrÉ syndrome, GBS) and chronic (CIDP, dysproteinemic) forms which differ primarily in their temporal profile.
Albers, James W., Kelly, John J.
core   +1 more source

Cytomegalovirus-related Guillain-Barre syndrome in an adult liver transplant recipient: a case report

open access: yesInfectio, 2023
Guillain-Barré syndrome (GBS) is an immune-mediated condition affecting both the motor and sensory spinal roots and peripheric nerves. GBS is a rare entity, with its global incidence being as low as 0.81 to 1.89 cases per 100.000 person-year. Despite its
Diana Marcela Hoyos-Llanos
doaj   +1 more source

Biological Drivers of IMiD‐Induced Peripheral Neuropathy in Multiple Myeloma

open access: yeseJHaem, Volume 7, Issue 3, June 2026.
ABSTRACT The introduction of immunomodulatory drugs (IMiDs), such as thalidomide, lenalidomide and pomalidomide, have led to significant improvements in multiple myeloma (MM) treatment. Many patients now live 10 years or longer with their disease, making treatment‐related side effects increasingly important.
Sina A. Beer   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy